CG24

Lung cancer (CG24) (replaced by CG121)

  • Clinical guidelines CG24
  • Issued: February 2005
    • Lung cancer: diagnosis and treatment

      This guidance has been replaced by CG121 Lung cancer

      • This guidance replaces and incorporates TA26 Lung cancer - docetaxel, paclitaxel, gemcitabine and vinorelbine.

      • Other information

        How this guidance was produced

        Background information

        • None found

      This page was last updated: 20 December 2011

    • Guideline formats

      Query

Implementation tools and resources

  • None available

See this guidance in practice

Patient

The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.

Quick Reference Guide

The quick reference guide presents recommendations for health professionals

NICE Guideline

The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.

Full Guideline

The published full clinical guideline for specialists with background, evidence, recommendations and methods used.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright @ 2012 National Institute for Health and Clinical Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright @ 2012 National Institute for Health and Clinical Excellence. All rights reserved.